Neuroscience 2014

Posted November 2014

Circuit Therapeutics will present studies on optogenetic driven understandings of Parkinson’s Disease on Wednesday, November 19 at the Walter E. Washington Convention Center, Washington DC. These studies demonstrate the power of optogenetic control to develop new models and therapeutically relevant understandings of disease that can drive the path to testing drugs and addressing a wide range of disease relevant symptoms.

Read our abstract here